देश: यूनाइटेड किंगडम
भाषा: अंग्रेज़ी
स्रोत: myHealthbox
cyproterone acetate, ethinylestradiol
Morningside Healthcare Ltd
G03HB01
cyproterone acetate, ethinylestradiol
2000/35microgram
Film-coated tablets
Oral use
Packs of 21, 63 and 126 Tablets
POM - Prescription Only Medicine
Morningside Pharmaceutical Ltd
cyproterone and estrogen
Treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age. For the treatment of acne, co-cyprindiol should only be used after topical therapy or systemic antibiotic treatments have failed.
Authorised
2015-03-03
------------------------- DOCUMENT OUTLINE * Page 1 पूरा दस्तावेज़ पढ़ें
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Teragezza 2000/35 microgram film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Actives: Cyproterone acetate 2.00 mg Ethinylestradiol 35 micrograms Excipients: Lactose monohydrate 57.44mg For full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Film-coated tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age. For the treatment of acne, co-cyprindiol should only be used after topical therapy or systemic antibiotic treatments have failed. Since co-cyprindiol is also a hormonal contraceptive, it should not be used in combination with other hormonal contraceptives (see section 4.3). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Co-cyprindiol inhibits ovulation and thereby prevents conception. Patients who are using co-cyprindiol should not therefore use an additional hormonal contraceptive, as this will expose the patient to an excessive dose of hormones and is not necessary for effective contraception. _First treatment course:_ One tablet daily for 21 days, starting on the first day of the menstrual cycle (the first day of menstruation counting as Day 1). _Subsequent courses:_ Each subsequent course is started after 7 tablet-free days have followed the preceding course. When the contraceptive action of co-cyprindiol is also to be employed, it is essential that the above instructions be rigidly adhered to. Should bleeding fail to occur during the tablet-free interval, the possibility of pregnancy must be excluded before the next pack is started. When changing from an oral contraceptive and relying on the con पूरा दस्तावेज़ पढ़ें